| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
13,613,607 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$52,115,053 |
|
|
| Total
Shares |
13,613,607 |
|
|
| Total
Value |
$52,115,053 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
3
|
|
Stock
price went up :
|
58
|
1
|
| Stock
price went down : |
65
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 10.2%
|
 -104.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-10 |
2,380,294 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2023-11-10 |
4 |
S |
$0.29 |
$1,401,571 |
I/I |
(4,764,008) |
0 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-04-08 |
4 |
B |
$4.80 |
$37,364 |
I/I |
7,791 |
128 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-16 |
4 |
S |
$4.86 |
$60,472 |
I/I |
(12,438) |
85,000 |
0 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-15 |
4 |
S |
$4.80 |
$14,405 |
I/I |
(3,000) |
85,938 |
0 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-08 |
4 |
S |
$6.10 |
$321,285 |
I/I |
(52,661) |
86,438 |
0 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-05 |
4 |
S |
$6.30 |
$1,056,701 |
I/I |
(167,701) |
89,099 |
0 |
- |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-06-10 |
4 |
B |
$5.60 |
$154,066 |
I/I |
27,500 |
95,000 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-06-10 |
4 |
B |
$6.50 |
$15,599 |
I/I |
2,400 |
97,400 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-04 |
4 |
S |
$6.44 |
$551,651 |
I/I |
(85,700) |
97,500 |
0 |
- |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-06-22 |
4 |
B |
$6.99 |
$16,776 |
I/I |
2,400 |
97,800 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-06-30 |
4 |
B |
$7.00 |
$24,955 |
I/I |
3,565 |
98,367 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-01 |
4 |
B |
$7.00 |
$1,400 |
I/I |
200 |
98,567 |
1.42 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-20 |
4 |
B |
$8.08 |
$41,192 |
I/I |
5,100 |
99,167 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-21 |
4 |
B |
$8.03 |
$83,010 |
I/I |
10,333 |
100,000 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-22 |
4 |
B |
$8.02 |
$41,709 |
I/I |
5,200 |
100,200 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-04 |
4 |
B |
$6.50 |
$42,621 |
I/I |
6,557 |
100,557 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-08-01 |
4 |
B |
$7.96 |
$39,632 |
I/I |
4,979 |
100,679 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-03 |
4 |
S |
$6.53 |
$760,850 |
I/I |
(116,500) |
101,500 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-17 |
4 |
B |
$6.98 |
$63,644 |
I/I |
9,118 |
101,647 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-18 |
4 |
B |
$6.98 |
$106,130 |
I/I |
15,206 |
102,647 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-16 |
4 |
B |
$6.41 |
$48,485 |
I/I |
7,563 |
103,710 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-17 |
4 |
B |
$6.60 |
$18,414 |
I/I |
2,790 |
104,200 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-23 |
4 |
B |
$6.60 |
$8,580 |
I/I |
1,300 |
105,000 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-08-10 |
4 |
B |
$8.52 |
$102,089 |
I/I |
11,979 |
105,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-27 |
4 |
B |
$6.53 |
$239,713 |
I/I |
36,700 |
110,000 |
1.5 |
% |
|
157 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
